Recently, gain of Twist1 and loss of E-cadherin observed in GBM specimens were correlated with shorter survival and poor temozolomide response in GBM patients, suggesting the involvement of EMT in GBM progression [23, 24]. This evidence concerns the gene TWIST1 and glioblastoma.